Ad Astra Diagnostics Files 510(k) for Hematology Analyzer System
Ad Astra Diagnostics submitted a 510(k) application to the FDA for its QScout RLD rapid-result hematology system.
Read MorePosted by Andy Lundin | Apr 3, 2023 | Hematology Instrumentation |
Ad Astra Diagnostics submitted a 510(k) application to the FDA for its QScout RLD rapid-result hematology system.
Read MorePosted by Andy Lundin | Mar 30, 2023 | Prostate |
A rapid test for advanced prostate cancer can quickly identify people with “actionable” gene variants eligible for new targeted therapies.
Read MorePosted by Chris Wolski | Mar 28, 2023 | Covid 19, Diagnostic Technologies, Flu & Respiratory Infections |
Scientists report using a nanomaterials-based sensor that can detect the presence of the viruses that cause COVID-19 and the flu.
Read MorePosted by Chris Wolski | Mar 28, 2023 | POC Rapid Assays, Sexually Transmitted Diseases |
A quick, affordable diagnostic finger-prick test may help curb one of the most prevalent but least discussed sexually transmitted infections.
Read MorePosted by Chris Wolski | Mar 28, 2023 | Molecular Diagnostic Analyzers, Sexually Transmitted Diseases |
Planned Parenthood Mar Monte (PPMM) has teamed with BD to provide STI testing for the most common infections to underserved populations.
Read More